Sepgard AR Gel

It is a research formulation of Themis Medicare Limited. Sepgard AR Gel is a unique combination of centbucridine and feracrylum, the two research molecules of Themis Medicare Limited. It is indicated in the treatment of haemorrhoides, anal fissures and proctitis. Centbucridine in Sepgard AR gel exerts anaesthetic action and thus reduces pain, produces vasoconstriction and thereby reduces bleeding and reduces itching by its antihistaminic action. Feracrylum due to its haemostatic action reduces bleeding and due to its antimicrobial action prevents infections.